Literature DB >> 12566449

Mechanistic differences in the activation of estrogen receptor-alpha (ER alpha)- and ER beta-dependent gene expression by cAMP signaling pathway(s).

Kevin M Coleman1, Martin Dutertre, Abeer El-Gharbawy, Brian G Rowan, Nancy L Weigel, Carolyn L Smith.   

Abstract

Although increases in intracellular cAMP can stimulate estrogen receptor-alpha (ER alpha) activity in the absence of exogenous hormone, no studies have addressed whether ER beta can be similarly regulated. In transient transfections, forskolin plus 3-isobutyl-1-methylxanthine (IBMX), which increases intracellular cAMP, stimulated the transcriptional activities of both ER alpha and ER beta. This effect was blocked by the protein kinase A inhibitor H89 (N-(2-(p-bromocinnamylamino)-ethyl)-5-isoquinolinesulfonamide) and was dependent on an estrogen response element. A 12-O-tetradecanoylphorbol-13-acetate response element (TRE) located 5' to the estrogen response element was necessary for cAMP-dependent activation of gene expression by ER beta but not ER alpha, indicating that the former subtype requires a functional interaction with TRE-interacting factor(s) to stimulate transcription. Both p160 and CREB-binding protein coactivators stimulated cAMP-induced ER alpha and ER beta transcriptional activity. However, mutation of the two cAMP-inducible SRC-1 phosphorylation sites important for cAMP activation of chicken progesterone receptor or all seven known SRC-1 phosphorylation sites did not specifically impair cAMP activation of ER alpha. The E/F domains of ER alpha are sufficient for activation by forskolin/IBMX, and this is accompanied by an increase in receptor phosphorylation. In contrast, cAMP signaling reduces the phosphorylation of the corresponding region of ER beta, and this correlates with the lack of forskolin/IBMX stimulated transcriptional activity. Our data suggest that cAMP activation of ER alpha transcriptional activity is associated with receptor instead of SRC-1 phosphorylation. Moreover, differences in the cofactor requirements, domains of ER alpha and ER beta sufficient for forskolin/IBMX activation, and the effect of cAMP on receptor phosphorylation indicate that this signaling pathway utilizes distinct mechanisms to stimulate ER alpha and ER beta transcriptional activity.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2003        PMID: 12566449     DOI: 10.1074/jbc.M212312200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice.

Authors:  Beata Lontay; Khaldon Bodoor; Adrienn Sipos; Douglas H Weitzel; David Loiselle; Rachid Safi; Donghai Zheng; James Devente; Robert C Hickner; Donald P McDonnell; Thomas Ribar; Timothy A Haystead
Journal:  J Biol Chem       Date:  2015-06-05       Impact factor: 5.157

2.  CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP.

Authors:  Sophie Carascossa; Peter Dudek; Bruno Cenni; Pierre-André Briand; Didier Picard
Journal:  Genes Dev       Date:  2010-04-01       Impact factor: 11.361

3.  Rapid estrogen-induced phosphorylation of the SRC-3 coactivator occurs in an extranuclear complex containing estrogen receptor.

Authors:  Fuzhong F Zheng; Ray-Chang Wu; Carolyn L Smith; Bert W O'Malley
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 4.  Liganded and unliganded activation of estrogen receptor and hormone replacement therapies.

Authors:  Adriana Maggi
Journal:  Biochim Biophys Acta       Date:  2011-05-14

5.  Alterations in reproductive function in SRC tyrosine kinase knockout mice.

Authors:  Katherine F Roby; Deok-Soo Son; Christopher C Taylor; Valerie Montgomery-Rice; Jeremy Kirchoff; Sandy Tang; Paul F Terranova
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

Review 6.  Steroid receptor phosphorylation: Assigning function to site-specific phosphorylation.

Authors:  Robert D Ward; Nancy L Weigel
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

Review 7.  Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus.

Authors:  T A Roepke; J Qiu; M A Bosch; O K Rønnekleiv; M J Kelly
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

8.  Estrogen receptor independent neurotoxic mechanism of bisphenol A, an environmental estrogen.

Authors:  Yoot Mo Lee; Min Jae Seong; Jae Woong Lee; Yong Kyung Lee; Tae Myoung Kim; Sang Yoon Nam; Dae Joong Kim; Young Won Yun; Tae Seong Kim; Soon Young Han; Jin Tae Hong
Journal:  J Vet Sci       Date:  2007-03       Impact factor: 1.672

9.  The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.

Authors:  Theresa J Peterson; Sudipan Karmakar; Margaret C Pace; Tong Gao; Carolyn L Smith
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

10.  Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species.

Authors:  D Montague; C S Weickert; E Tomaskovic-Crook; D A Rothmond; J E Kleinman; D R Rubinow
Journal:  J Neuroendocrinol       Date:  2008-04-28       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.